C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells

Biochemical and Biophysical Research Communications

Volumn 441, Issue 1, 2013, Pages 186-190

  Guo, Pin ^a   Nie, Quanmin ^a   Lan, Jin ^a   Ge, Jianwei ^a   Qiu, Yongming ^a,b   Mao, Qing ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Institute of Head Trauma   (China)

Author keywords

C Myc; Glioblastoma multiforme; MiR 26a; Proliferation; PTEN

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MICRORNA 26A; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; 3' UNTRANSLATED REGION; MICRORNA; MIRN26A MICRORNA, HUMAN; PROTEIN KINASE B; PTEN PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENETIC ASSOCIATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; UPREGULATION; BRAIN TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MYC; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84887458429     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.10.034     Document Type: Article

References (34)

1. C. Wang, M.P. Lisanti, and D.J. Liao Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology Cell Cycle 10 2011 57 67
2. C.D. Little, M.M. Nau, D.N. Carney, A.F. Gazdar, and J.D. Minna Amplification and expression of the c-myc oncogene in human lung cancer cell lines Nature 306 1983 194 196
3. J. Qian, R.B. Jenkins, and D.G. Bostwick Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization Mod. Pathol. 10 1997 1113 1119
4. H.R. Abeysinghe, E. Cedrone, T. Tyan, J. Xu, and N. Wang Amplification of C-MYC as the origin of the homogeneous staining region in ovarian carcinoma detected by micro-FISH Cancer Genet. Cytogenet. 114 1999 136 143
5. J.S. Choi, J. Seo, E.J. Jung, E.J. Kim, G.K. Lee, and W.H. Kim C-MYC amplification in mucinous gastric carcinoma: a possible genetic alteration leading to deeply invasive tumors Anticancer Res. 32 2012 5031 5037
6. F. Bourdeaut, C. Grison, C.A. Maurage, A. Laquerriere, A. Vasiljevic, M.B. Delisle, S. Michalak, D. Figarella-Branger, F. Doz, W. Richer, G. Pierron, C. Miquel, O. Delattre, and J. Couturier MYC and MYCN amplification can be reliably assessed by aCGH in medulloblastoma Cancer Genet. 206 2013 124 129
7. C.V. Dang, L.M. Resar, E. Emison, S. Kim, Q. Li, J.E. Prescott, D. Wonsey, and K. Zeller Function of the c-Myc oncogenic transcription factor Exp. Cell Res. 253 1999 63 77
8. D.Y. Mao, D. Barsyte-Lovejoy, C.S. Ho, J.D. Watson, A. Stojanova, and L.Z. Penn Promoter-binding and repression of PDGFRB by c-Myc are separable activities Nucleic Acids Res. 32 2004 3462 3468
9. F.J. Swartling Myc proteins in brain tumor development and maintenance Ups. J. Med. Sci. 117 2012 122 131
10. J. Wang, H. Wang, Z. Li, Q. Wu, J.D. Lathia, R.E. McLendon, A.B. Hjelmeland, and J.N. Rich C-Myc is required for maintenance of glioma cancer stem cells PLoS One 3 2008 e3769
11. S. Sander, L. Bullinger, K. Klapproth, K. Fiedler, H.A. Kestler, T.F. Barth, P. Moller, S. Stilgenbauer, J.R. Pollack, and T. Wirth MYC stimulates EZH2 expression by repression of its negative regulator miR-26a Blood 112 2008 4202 4212
12. J.W. Kim, S. Mori, and J.R. Nevins Myc-induced microRNAs integrate Myc-mediated cell proliferation and cell fate Cancer Res. 70 2010 4820 4828
13. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
14. P. Gao, I. Tchernyshyov, T.C. Chang, Y.S. Lee, K. Kita, T. Ochi, K.I. Zeller, A.M. De Marzo, J.E. Van Eyk, J.T. Mendell, and C.V. Dang C-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism Nature 458 2009 762 765
15. T.C. Chang, D. Yu, Y.S. Lee, E.A. Wentzel, D.E. Arking, K.M. West, C.V. Dang, A. Thomas-Tikhonenko, and J.T. Mendell Widespread microRNA repression by Myc contributes to tumorigenesis Nat. Genet. 40 2008 43 50
16. X. Zhao, T. Lwin, X. Zhang, A. Huang, J. Wang, V.E. Marquez, S. Chen-Kiang, W.S. Dalton, E. Sotomayor, and J. Tao Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity Leukemia 2013 10.1038/leu.2013.94 [Epub ahead of print]
17. H. Kim, W. Huang, X. Jiang, B. Pennicooke, P.J. Park, and M.D. Johnson Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship Proc. Natl. Acad. Sci. USA 107 2010 2183 2188
18. K.A. McDowell, G.J. Riggins, and G.L. Gallia Targeting the AKT pathway in glioblastoma Curr. Pharm. Des. 17 2011 2411 2420
19. J.R. Molina, F.C. Morales, Y. Hayashi, K.D. Aldape, and M.M. Georgescu Loss of PTEN binding adapter protein NHERF1 from plasma membrane in glioblastoma contributes to PTEN inactivation Cancer Res. 70 2010 6697 6703
20. P.S. Mischel, and T.F. Cloughesy Targeted molecular therapy of GBM Brain Pathol. 13 2003 52 61
21. J. Trent, P. Meltzer, M. Rosenblum, G. Harsh, K. Kinzler, R. Mashal, A. Feinberg, and B. Vogelstein Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma Proc. Natl. Acad. Sci. USA 83 1986 470 473
22. T. Cenci, M. Martini, N. Montano, Q.G. D'Alessandris, M.L. Falchetti, D. Annibali, M. Savino, F. Bianchi, F. Pierconti, S. Nasi, R. Pallini, and L.M. Larocca Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma Am. J. Clin. Pathol. 138 2012 390 396
23. J. Kim, I.E. Eltoum, M. Roh, J. Wang, and S.A. Abdulkadir Interactions between cells with distinct mutations in c-MYC and Pten in prostate cancer PLoS Genet. 5 2009 e1000542
24. X. Huang, Y. Zhang, Y. Tang, N. Butler, J. Kim, F. Guessous, D. Schiff, J. Mandell, and R. Abounader A novel PTEN/Mutant p53/c-Myc/Bcl-XL axis mediates context-dependent oncogenic effects of PTEN with implications for cancer prognosis and therapy Neoplasia 15 2013 952 965
25. M. Bonnet, M. Loosveld, B. Montpellier, J.M. Navarro, B. Quilichini, C. Picard, J. Di Cristofaro, C. Bagnis, C. Fossat, L. Hernandez, E. Mamessier, S. Roulland, E. Morgado, C. Formisano-Treziny, W.A. Dik, A.W. Langerak, T. Prebet, N. Vey, G. Michel, J. Gabert, J. Soulier, E.A. Macintyre, V. Asnafi, D. Payet-Bornet, and B. Nadel Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia Blood 117 2011 6650 6659
26. T.V. Bui, and J.T. Mendell Myc: Maestro of MicroRNAs Genes Cancer 1 2010 568 575
27. B. Luscher, and L.G. Larsson The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation Oncogene 18 1999 2955 2966
28. A. Cascon, and M. Robledo MAX and MYC: a heritable breakup Cancer Res. 72 2012 3119 3124
29. X. Wang, X. Zhao, P. Gao, and M. Wu C-Myc modulates microRNA processing via the transcriptional regulation of Drosha Sci. Rep. 3 2013 1942
30. K.A. O'Donnell, E.A. Wentzel, K.I. Zeller, C.V. Dang, and J.T. Mendell C-Myc-regulated microRNAs modulate E2F1 expression Nature 435 2005 839 843
31. P. Kumar, Y. Luo, C. Tudela, J.M. Alexander, and C.R. Mendelson The c-Myc-regulated microRNA-17∼92 (miR-17∼92) and miR-106a∼363 clusters target hCYP19A1 and hGCM1 to inhibit human trophoblast differentiation Mol. Cell. Biol. 33 2013 1782 1796
32. A. Frenzel, J. Loven, and M.A. Henriksson Targeting MYC-regulated miRNAs to combat cancer Genes Cancer 1 2010 660 667
33. M. de Tayrac, A. Etcheverry, M. Aubry, S. Saikali, A. Hamlat, V. Quillien, A. Le Treut, M.D. Galibert, and J. Mosser Integrative genome-wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression Genes Chromosom. Cancer 48 2009 55 68
34. L.S. Steelman, R.A. Franklin, S.L. Abrams, W. Chappell, C.R. Kempf, J. Basecke, F. Stivala, M. Donia, P. Fagone, F. Nicoletti, M. Libra, P. Ruvolo, V. Ruvolo, C. Evangelisti, A.M. Martelli, and J.A. McCubrey Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy Leukemia 25 2011 1080 1094